Literature DB >> 16835587

Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.

Vincenzo Bonifati1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16835587     DOI： 10.1038/sj.ejhg.5201695

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  18 in total

1.  The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.

Authors:  Lizhen Wang; Chengsong Xie; Elisa Greggio; Loukia Parisiadou; Hoon Shim; Lixin Sun; Jayanth Chandran; Xian Lin; Chen Lai; Wan-Jou Yang; Darren J Moore; Ted M Dawson; Valina L Dawson; Gabriela Chiosis; Mark R Cookson; Huaibin Cai
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

2.  Synthesis and In Vitro and In Vivo Evaluation of [3H]LRRK2-IN-1 as a Novel Radioligand for LRRK2.

Authors:  Noeen Malik; Andrew N Gifford; Johan Sandell; Daniel Tuchman; Yu-Shin Ding
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

Review 3.  Endocytic membrane trafficking and neurodegenerative disease.

Authors:  Andrea M A Schreij; Edward A Fon; Peter S McPherson
Journal:  Cell Mol Life Sci       Date:  2015-12-31       Impact factor: 9.261

Review 4.  Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease.

Authors:  Stefan W Ryter; Divya Bhatia; Mary E Choi
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 5.  Mitochondria: Powering the Innate Immune Response to Mycobacterium tuberculosis Infection.

Authors:  Kristin L Patrick; Robert O Watson
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 6.  Effects of bile acids on neurological function and disease.

Authors:  Matthew McMillin; Sharon DeMorrow
Journal:  FASEB J       Date:  2016-07-28       Impact factor: 5.191

Review 7.  Parkinson's disease: Exit toxins, enter genetics.

Authors:  Marie Westerlund; Barry Hoffer; Lars Olson
Journal:  Prog Neurobiol       Date:  2009-11-17       Impact factor: 11.685

8.  Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Authors:  Min Liu; Samantha A Bender; Gregory D Cuny; Woody Sherman; Marcie Glicksman; Soumya S Ray
Journal:  Biochemistry       Date:  2013-03-01       Impact factor: 3.162

9.  Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis.

Authors:  Loukia Parisiadou; Chengsong Xie; Hyun Jin Cho; Xian Lin; Xing-Long Gu; Cai-Xia Long; Evy Lobbestael; Veerle Baekelandt; Jean-Marc Taymans; Lixin Sun; Huaibin Cai
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

Review 10.  LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.

Authors:  Vincenzo Bonifati
Journal:  Neurochem Res       Date:  2007-04-18       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.